Drug intelligence / Profile preview

Regenecare HA

Development stage
Unknown
Lead developer
MPM Medical
Modality
Small Molecules
Administration
Topical
01

Overview

Regenecare HA is an over-the-counter topical hydrogel manufactured by MPM Medical LLC. The product is formulated with 2% lidocaine hydrochloride as its active pharmaceutical ingredient, which provides temporary relief from pain and itching by acting as a topical anesthetic and analgesic. In addition to lidocaine, the hydrogel contains hyaluronic acid, collagen (procollagen), aloe vera, and allantoin. These ingredients work synergistically to manage wounds by moisturizing damaged tissue and supporting the natural healing processes, including granulation tissue formation, reepithelization, and remodeling. Regenecare HA is available in gel and spray forms and is indicated for minor burns, sunburn, minor cuts, scrapes, insect bites, and other minor skin irritations.

Brand names
Regenecare HA
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Regenecare HA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenecare HA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call